Upexi, Inc. (UPXI) Q2 2026 Earnings Call February 10, 2026 5:30 PM EST
Company Participants
Allan Marshall - CEO, President & Chairman of the Board
Brian Rudick - Chief Strategy Officer
Andrew Norstrud - CFO & Director
Conference Call Participants
Valter Pinto - Kanan, Corbin, Schupak & Aronow, Inc.
Brian Kinstlinger - Alliance Global Partners, Research Division
Brett Knoblauch - Cantor Fitzgerald & Co., Research Division
Presentation
Operator
Good day. Welcome to Upexi Inc. Fiscal Second Quarter 2026 Financial Results Conference Call. Please note this event is being recorded.
I would now like to turn the conference over to Valter Pinto, Managing Director at KCSA Strategic Communications. Please go ahead.
Valter Pinto
Kanan, Corbin, Schupak & Aronow, Inc.
Thank you, operator. Good evening, and welcome, everyone, to the Upexi Fiscal Second Quarter 2026 Financial Results Conference Call. I'm joined today by Allan Marshall, Chief Executive Officer; Andrew Norstrud, Chief Financial Officer; and Brian Rudick, Chief Strategy Officer.
Before we begin, I'm going to remind everyone that statements made during today's conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially due to a variety of risks, uncertainties and other factors. For a detailed discussion of some of the ongoing risks and uncertainties in the company's business, I'll refer you to the press release issued this evening and filed with the SEC on Form 8-K as well as the company's reports filed periodically with the SEC. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless otherwise required by law.
In addition, during the course of the call, we may refer to non-GAAP financial measures that are not prepared in accordance
2026-02-11 03:111mo ago
2026-02-10 21:551mo ago
Ardent Health Corporation Securities Fraud Class Action Result of Undisclosed Collections Problems and 33% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle District of Tennessee.
What You May Do
If you purchased securities of Ardent and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-ardt/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by March 9, 2026.
About the Lawsuit
Ardent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On November 12, 2025, post-market, the Company disclosed a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability after the Company transitioned to a new revenue accounting system and from purported “recently completed hindsight evaluations of historical collection trends.” The Company further disclosed a cut to 2025 EBITDA guidance of $57.5 million at the midpoint, or about 9.6%, from $575 million – $625 million to $530 million – $555 million due to “persistent industry-wide cost pressures,” including “payer denials,” and also recorded a $54 million increase in professional liability reserves “with respect to recent settlements and ongoing litigation arising from a limited set of claims between 2019 and 2022 in New Mexico” as well as “consideration of broader industry trends, including social inflationary pressures.”
On this news, the price of Ardent’s shares fell $4.75 per share, or nearly 34%, from $14.05 per share on November 12, 2025, to close at $9.30 per share on November 13, 2025, on unusually heavy trading volume.
The case is Postiwala v. Ardent Health, Inc., et al., No. 26-cv-00022.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK CITY and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NasdaqGS: RARE) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of Ultragenyx who were adversely affected by alleged securities fraud between August 3, 2023 and December 26, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nasdaqgs-rare/
Ultragenyx investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-rare/ to learn more.
CASE DETAILS: On December 26, 2025, the Company announced the “results from the Phase 3 Orbit and Cosmic studies for setrusumab (UX143) in Osteogenesis Imperfecta” disclosing that both its Phase III Orbit and Cosmic studies failed to demonstrate that setrusumab triggered a statistically significant reduction in annualized fracture rates for patients with osteogenesis imperfecta, and, as a result the Company “is evaluating its planned operations and will promptly define and implement significant expense reductions.” On this news, the price of Ultragenyx’s shares fell approximately 42%, from $34.19 per share on December 26, 2025 to $19.72 per share on December 29, 2025.
The case is Steven Bailey v. Ultragenyx Pharmaceutical Inc., et al., No. 26-cv-01097.
WHAT TO DO? If you invested in Ultragenyx and suffered a loss during the relevant time frame, you have until April 6, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
BellRing Brands, Inc. Securities Fraud Class Action Result of Inventory Issues and 52% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
NEW YORK CITY and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until March 23, 2026 to file lead plaintiff applications in a securities class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR), if they purchased or otherwise acquired the Company’s securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.
What You May Do
If you purchased securities of BellRing and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nyse-brbr/ to learn more. If you wish to serve as a lead plaintiff in this class action, you must petition the Court by March 23, 2026.
About the Lawsuit
BellRing and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On May 6, 2025, the Company disclosed that “several key retailers lowered their weeks of supply on hand, which is expected to be a mid-single-digit headwind to our third quarter growth,” and that “[w]e now expect Q3 sales growth of low single digits.” On this news, the price of BellRing’s shares fell $14.88 per share, or 19%, from $78.43 per share on May 5, 2025, to close at $63.55 per share on May 6, 2025, on unusually heavy trading volume.
Then, on August 4, 2025, post-market, the Company reported its fiscal 3Q 2025 financial results, disclosing a disappointing new 2025 sales outlook, stating “BellRing management has narrowed its fiscal year 2025 outlook for net sales to [a] range between $2.28-$2.32 billion,” due to “several other competitors” gaining space to sell their products with a large retailer and that “it is not surprising to see new protein RTDs enter[ed]” the convenient nutrition market. On this news, the price of BellRing’s shares fell $17.46 per share, or nearly 33%, from $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025, on unusually heavy trading volume.
The case is Denha v. BellRing Brands, Inc., No. 26-cv-00575.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
NEW YORK and NEW ORLEANS, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in CoreWeave, Inc. (“CoreWeave” or the “Company”) (NasdaqGS: CRWV) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of CoreWeave who were adversely affected by alleged securities fraud between March 28, 2025 and December 15, 2025. Follow the link below to get more information and be contacted by a member of our team:
https://www.ksfcounsel.com/cases/nasdaqgs-crwv/
CoreWeave investors should contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-crwv/ to learn more.
CASE DETAILS: According to the Complaint, CoreWeave and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws. The alleged false and misleading statements and omissions include, but are not limited to, that: (i) the Company had overstated its ability to meet customer demand for its service; (ii) the Company materially understated the scope and severity of the risk that its reliance on a single third-party data center supplier created for its ability to meet customer demand for its services; (iii) the foregoing was reasonably likely to have a material negative impact on the Company’s revenue; and (iv) as a result, CoreWeave's public statements were materially false and misleading at all relevant times.
The case is Masaitis v. CoreWeave, Inc., et al., No. 26-cv-00355.
WHAT TO DO? If you invested in CoreWeave and suffered a loss during the relevant time frame, you have until March 13, 2026 to request that the Court appoint you as lead plaintiff; however, your ability to share in any recovery does not require that you serve as a lead plaintiff.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner [email protected]
1-877-515-1850
1100 Poydras St., Suite 960
New Orleans, LA 70163
New York, New York--(Newsfile Corp. - February 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Varonis Systems, Inc. (NASDAQ: VRNS) between February 4, 2025 and October 28, 2025, both dates inclusive (the "Class Period"), of the important March 9, 2026 lead plaintiff deadline.
SO WHAT: If you purchased Varonis common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Varonis class action, go to https://rosenlegal.com/submit-form/?case_id=50337 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 9, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants made materially false and/or misleading statements and or failed to disclose that: (1) Varonis would not be able to maintain ARR projections while converting both its federal and non-federal existing on-prem customers to the software-as-a-service ("SaaS") alternative offering; (2) Varonis was not equipped to convince existing users of the benefits of converting to the SaaS offering or otherwise maintain these customers on its platform, resulting in significantly reduced ARR growth potential in the near-term; and (3) as a result of the foregoing, defendants' positive statements about Varonis' business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Varonis class action, go to https://rosenlegal.com/submit-form/?case_id=50337 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
-------------------------------
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283451
Source: The Rosen Law Firm PA
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
SummaryMicrosoft now trades at rare value levels, with a 25% drawdown and a trailing P/E of 24.5x, despite robust fundamentals.Market fears over cloud growth and aggressive AI-driven capex appear overblown given MSFT's strong balance sheet and consistent free cash flow.MSFU, the 2x leveraged ETF, offers potential upside but carries amplified risk; technical signals currently advise caution before entering.Leveraged ETF positions like MSFU demand strict risk controls, modest position sizing, and disciplined exit strategies to mitigate volatility drag and compounding losses.Getty Images
Microsoft (MSFT) is increasingly looking like a value play - and so is the Direxion Daily MSFT Bull 2X Shares ETF (MSFU), which is now in a 50% drawdown that took shape very quickly. Since MSFT peaked
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Ichor crushed expectations in Q4 and issued promising guidance.
Ichor Holdings (ICHR +32.72%) surged higher Tuesday. The fluid-delivery-subsystems company's share price closed out the daily session up 32.7%. Meanwhile, the S&P 500 was down 0.4% and the Nasdaq Composite was down 0.6%.
Ichor published its fourth-quarter earnings report after the market closed yesterday, and performance crushed expectations. The company also issued great forward guidance.
Image source: Getty Images.
Ichor surged after topping Q4 sales and earnings expectations Ichor reported non-GAAP (adjusted) earnings per share of $0.07 for the fourth quarter, far exceeding the average Wall Street analyst estimate of a per-share loss of $0.06. Meanwhile, sales came in at $223.6 million -- beating the average Wall Street target by $2.76 million.
Ichor's revenue was still down 4% year over year, but demand in the semiconductor segment and rising growth in the commercial manufacturing category helped power a big earnings beat. While the company's adjusted gross margin dropped to 11.7% from 12% in the prior-year quarter, management noted that the business was still in the early stages of seeing the benefits of steps taken to boost margins.
Today's Change
(
32.72
%) $
11.16
Current Price
$
45.27
What's next for Ichor? Ichor expects continued strengthening in commercial manufacturing and thinks there's a chance that growth in the category will eclipse the expansion seen in semiconductor sales. Despite the sales decline in Q4, management anticipates that revenue will increase sequentially in each quarter this year.
For the current quarter, Ichor expects that sales will come in between $240 million and $260 million. At the midpoint of the target range, this would mean year-over-year sales growth of roughly 12%. Meanwhile, gross margins are projected to rise to between 12% and 13%. On the strength of strong sales growth and expanding gross margins, the company's target for adjusted earnings per share between $0.08 and $0.16 suggests that earnings will be roughly in line with last year's quarter despite increased spending to drive growth.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-02-11 02:111mo ago
2026-02-10 20:171mo ago
Activist investor Ancora pushes Warner Bros to walk away from Netflix deal, WSJ reports
The Warner Bros logo is seen during the annual MIPCOM television programme market in Cannes, France, October 14, 2019. REUTERS/Eric Gaillard/File Photo Purchase Licensing Rights, opens new tab
CompaniesFeb 10 (Reuters) - Activist investor Ancora Holdings has built a roughly $200 million stake in Warner Bros Discovery (WBD.O), opens new tab and plans to oppose Warner's deal to sell its prized TV and film assets to Netflix (NFLX.O), opens new tab, the Wall Street Journal reported on Tuesday.
Reuters could not immediately verify the report.
The Reuters Inside Track newsletter is your essential guide to the biggest events in global sport. Sign up here.
Reporting by Fabiola Arámburo in Mexico City; Editing by Rashmi Aich
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-02-11 02:111mo ago
2026-02-10 20:171mo ago
Robinhood stock drops following earnings, plus how AI is putting pressure on software companies
Yahoo Finance covers the latest financial news stories for Tuesday February 10, 2026. 0:00 Robinhood earnings About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life.
2026-02-11 02:111mo ago
2026-02-10 20:191mo ago
Oil holds steady as US–Iran tensions provide support
Oil platforms and pumpjacks at Lake Maracaibo, in Cabimas, Venezuela, January 26, 2026. REUTERS/Leonardo Fernandez Viloria/File Photo Purchase Licensing Rights, opens new tab
SINGAPORE, Feb 11 (Reuters) - Oil held steady on Wednesday, finding support as the market waited for direction while U.S.–Iran talks continued, with lingering geopolitical uncertainty helping to underpin prices.
Brent crude oil futures were up 23 cents, or 0.3%, at $69.03 a barrel by 0100 GMT. U.S. West Texas Intermediate crude rose 23 cents, or 0.4%, to $64.19.
The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.
Iran's foreign ministry spokesperson said on Tuesday that nuclear talks with the U.S. allowed Tehran to gauge Washington's seriousness and showed enough consensus to continue on the diplomatic track.
Diplomats from Iran and the U.S. held talks in Oman last week in an effort to revive diplomacy, after U.S. President Donald Trump positioned a naval flotilla in the region, raising fears of new military action.
While oil prices first eased after Oman's foreign minister said discussions tied to the U.S.-Iran talks with Iran's top security official were productive, hopes of a peaceful resolution were later dashed following reports that the U.S. may send a second aircraft carrier to the Middle East if talks fail, said ANZ analysts in a note.
Trump said on Tuesday he was considering sending a second aircraft carrier to the Middle East, even as Washington and Tehran prepare to resume negotiations aimed at averting a new conflict.
Traders are also waiting for weekly U.S. oil inventory data from the Energy Information Administration on Wednesday.
Analysts polled by Reuters estimated on average that crude inventories rose by about 800,000 barrels in the week to February 6, while distillate and gasoline inventories likely fell by about 1.3 million barrels and 400,000 barrels respectively.
U.S. crude inventories rose by 13.4 million barrels in the week ended February 6, market sources said, citing American Petroleum Institute figures on Tuesday.
Reporting by Emily Chow; Editing by Stephen Coates
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-02-11 02:111mo ago
2026-02-10 20:241mo ago
Linkage Global Sustains CES Momentum with Strong Sales Performance
, /PRNewswire/ -- Linkage Global Inc. (NASDAQ: LGCB), ("Linkage Global" or the "Company"), a public company that engages in providing cross-border e-commerce integrated services, today announced a continuation of its market momentum following a successful showcase at the 2026 Consumer Electronics Show (CES).
Building on strategic intellectual property (IP) partnerships announced at CES with premium brand ClickClack, the Company reported a new sales milestone for February. Linkage Global's licensed products achieved a sales volume of 72,000 units, generating USD 720,000 in patent licensing fees based on its structured royalty model of $10 per unit.
The ClickClack S7 All-Scenario Headphones—a collaborative product leveraging Linkage Global's patented core acoustic algorithms, craftsmanship designs, and smart wearable technology—have garnered positive market reception and rising sales. These innovations broke through traditional headphone functionality and were among the standout exhibits at CES 2026.
"Our partnerships with ClickClack validate the power of our IP portfolio and its applicability in next-generation consumer electronics," said Zhihua Wu, chairman of Linkage Global. "The market response has been very encouraging, and we are leveraging this momentum to scale our licensing model globally."
If the current sales performance is maintained, the company anticipates profitability in the first half of 2026. The continued demand for integrated smart audio-wearable solutions underscores Linkage Global's strategic positioning at the intersection of technology, design, and intellectual property monetization.
The order volume for March 2026 is expected to be announced by the 5th of next month, providing further insight into sustained sales traction and partnership execution.
About Linkage Global Inc.
Linkage Global Inc. (NASDAQ: LGCB) is a holding company, which engages in providing cross-border e-commerce integrated services. Through its operating entities, it developed a comprehensive service system comprised of two lines of business complementary to each other, including cross-border sales and integrated e-commerce services. It operates through the Extend and Other Subsidiaries segments. The company was founded on March 24, 2022 and is headquartered in Tokyo, Japan.
Lyft, Inc. (LYFT) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Erin Brewer - Chief Financial Officer
Erin Rheaume
John Risher - CEO & Director
Conference Call Participants
Eric Sheridan - Goldman Sachs Group, Inc., Research Division
Douglas Anmuth - JPMorgan Chase & Co, Research Division
John Blackledge - TD Cowen, Research Division
Charles Larkin - Oppenheimer & Co. Inc., Research Division
Nikhil Devnani - Bernstein Institutional Services LLC, Research Division
Benjamin Black - Deutsche Bank AG, Research Division
Michael Morton - MoffettNathanson LLC
Ross Sandler - Barclays Bank PLC, Research Division
Justin Post - BofA Securities, Research Division
Presentation
Erin Brewer
Chief Financial Officer
Good afternoon, everyone. This is Erin Brewer. Welcome to Lyft's Fourth Quarter and Full Year 2025 Earnings Call. As a reminder, this conference call is being recorded.
Before we start, I'd like to take a moment to share an update. Aurelien Nolf has accepted a new role and will be leaving Lyft. On behalf of David and myself, we are incredibly grateful for his contributions, and we wish him every success in his next chapter. I'm also pleased to welcome Erin Rheaume to the call today. Erin joined us in September 2024 as a Senior Director on our Investor Relations team, bringing a wealth of professional experience in Investor Relations. She's played an instrumental role in shaping our program since she joined, and I'm delighted that she'll be stepping in as Lyft's new Head of Investor Relations. You're all in great hands.
Turning over to you, Erin.
Erin Rheaume
Thanks, Erin. I just want to take a moment to echo the same thoughts we are so proud of our friend and our colleague and we'll be rooting for him in his new role.
Now let's dive in. On the call today, we have our CEO, David Risher; and our CFO, Erin Brewer. As a reminder, our
2026-02-11 02:111mo ago
2026-02-10 20:251mo ago
Prediction: This Iconic Stock Will Slash Its Dividend in 2026
For 15 years, Starbucks' (SBUX 1.46%) dividend growth couldn't be stopped. In 2010, in the shadow of the Great Recession, it issued its first dividend of $0.05 per share, which doubled less than three years later. Up through 2025, payouts grew by 1,140%, and anyone who had invested $1,000 on the eve of its first dividend in April 2010 would now be enjoying a yield on cost of 28% each year.
That's great income, but alas, this dividend growth is very likely in the past. As a shareholder, it pains me to say this, but I believe Starbucks' dividend growth will come to an abrupt halt later this year, as the company typically announces dividend hikes in October.
Here are the signs.
Image source: Getty Images.
Starbucks' dividend growth has sputtered big-time in recent years From 2010 to 2020, the company hiked its dividend by an average of 24.5% a year. But since 2021, dividend growth has slowed dramatically, as you can see below.
YearQuarterly PayoutAnnual Dividend Increase2021$0.49 per share8.9%2022$0.53 per share8.2%2023$0.57 per share7.5%2024$0.61 per share7%2025$0.62 per share1.6% Data source: Author calculations and Yahoo! Finance.
Slowing dividend growth may not tell us much by itself, not even a slowdown as sharp as this. After all, I argued recently that Coca-Cola's dividend growth will soon pick back up after a years-long slowdown. But Starbucks' token dividend growth in 2025 came alongside some worrying fundamentals.
2. Starbucks' payout ratio is soaring Over the last year, look what's happened to the payout ratio -- the percentage of net income that the company spends on its dividend.
Data by YCharts.
As you can see, it's now above 200%, meaning that it's spending over twice as much on its dividend as it takes in as net income.
That's a big warning sign, though admittedly not definitive. Cash from operations can offer better insight into a dividend's sustainability, since that metric shows what a company has left over after paying salaries, keeping the lights on, and all other operating costs.
3. Cash flow from operations is plummeting Starbucks' cash flow from operations has fallen from roughly $5.6 billion a year ago to just under $4.3 billion today.
Data by YCharts.
Ordinarily, I would look to share repurchase figures to see if the dividend might be more sustainable than it appears, thanks to a falling share count. But Starbucks hasn't repurchased shares since 2024, and its employee stock investment plan, which allows employees to buy stock at a 5% discount after 90 days of service, is actually expanding the number of shares outstanding and diluting the share price. The effect isn't massive, but it doesn't help a company that's holding onto its dividend by its fingernails.
Today's Change
(
-1.46
%) $
-1.44
Current Price
$
97.54
And speaking of share buybacks, shares of Starbucks slid in 2022 when then-CEO Howard Schultz suspended the company's buyback program, saying that cash was needed for investment in operations. Because buybacks don't carry the same prestige that consistently rising dividends do -- there are no "Buyback Aristocrats" of "Repurchase Kings" -- a dividend cut would likely hit shares much harder.
While CEO Brian Niccol might succeed in his turnaround mission at Starbucks, shares are more likely to be in for some short-term pain before that day arrives. For investors who prioritize income, this is one stock to avoid.
2026-02-11 02:111mo ago
2026-02-10 20:301mo ago
Compared to Estimates, Exelixis (EXEL) Q4 Earnings: A Look at Key Metrics
Exelixis (EXEL - Free Report) reported $598.66 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 5.6%. EPS of $0.94 for the same period compares to $0.55 a year ago.
The reported revenue represents a surprise of +2.39% over the Zacks Consensus Estimate of $584.68 million. With the consensus EPS estimate being $0.77, the EPS surprise was +22.25%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Exelixis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Net product revenues: $546.58 million versus $529.04 million estimated by nine analysts on average. Compared to the year-ago quarter, this number represents a +6.1% change.Revenues- Collaboration revenues: $52.09 million compared to the $49.91 million average estimate based on nine analysts. The reported number represents a change of +2289.3% year over year.Revenues- Net product revenues- CABOMETYX: $544.7 million compared to the $554.08 million average estimate based on seven analysts. The reported number represents a change of +6.2% year over year.Revenues- Net product revenues- COMETRIQ: $1.8 million versus the seven-analyst average estimate of $3.15 million. The reported number represents a year-over-year change of -25.6%.Revenues- Collaboration revenues- License revenues: $66.36 million versus the five-analyst average estimate of $48.87 million.View all Key Company Metrics for Exelixis here>>>
Shares of Exelixis have returned -0.3% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-02-11 02:111mo ago
2026-02-10 20:301mo ago
Compared to Estimates, Pegasystems (PEGA) Q4 Earnings: A Look at Key Metrics
Pegasystems (PEGA - Free Report) reported $504.32 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 2.8%. EPS of $0.76 for the same period compares to $0.81 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $484.73 million, representing a surprise of +4.04%. The company delivered an EPS surprise of +5.56%, with the consensus EPS estimate being $0.72.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Pegasystems performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenue- Subscription services: $272.79 million versus $269.79 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +18.2% change.Revenue- Subscription license: $178.22 million versus $160.35 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -12.9% change.Revenue- Consulting: $53.31 million versus the three-analyst average estimate of $55.34 million. The reported number represents a year-over-year change of +0.9%.Revenue- Pega Cloud: $193.49 million versus $190.38 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +29.3% change.Revenue- Maintenance: $79.31 million versus $79.41 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -2.4% change.Revenue- Subscription: $451.01 million versus the three-analyst average estimate of $430.14 million. The reported number represents a year-over-year change of +3.5%.Gross Profit- Subscription services: $226.16 million versus $221.35 million estimated by two analysts on average.Gross Profit- Subscription: $406.09 million versus $389.72 million estimated by two analysts on average.Gross Profit- Subscription license: $179.93 million versus the two-analyst average estimate of $168.37 million.View all Key Company Metrics for Pegasystems here>>>
Shares of Pegasystems have returned -28.2% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-02-11 02:111mo ago
2026-02-10 20:341mo ago
Ally Financial Inc. (ALLY) Presents at Bank of America Financial Services Conference 2026 Transcript
Ally Financial Inc. (ALLY) Bank of America Financial Services Conference 2026 February 10, 2026 4:20 PM EST
Company Participants
Sean Leary - Chief Financial Planning & Investor Relations Officer
Conference Call Participants
Brandon Berman - BofA Securities, Research Division
Presentation
Brandon Berman
BofA Securities, Research Division
Hello, everyone. My name is Brandon Berman. I am the senior mid-cap bank analyst here at Bank of America. And joining me today on stage for this fireside chat is Sean Leary. He's the Chief Financial Planning and Investor Relations Officer at Ally Financial.
Question-and-Answer Session
Brandon Berman
BofA Securities, Research Division
It seems like, Sean, you have a bit more of a unique role at Ally than your typical IR individual, right? And you have responsibilities that extend well beyond that function. And we appreciate you taking the time today to share some of your perspective. Anything that you want to talk about, about how '25 sort of played out that you're -- before we get to 2026?
Sean Leary
Chief Financial Planning & Investor Relations Officer
Sure. Yes, I would just say that across the board, really pleased with everything that we saw in 2025. We've been talking a lot about solid operational and execution across all of our businesses. But to see that manifest on the face of the financials was very encouraging. So we take a lot of comfort and confidence, just the underlying momentum that's built up in the business and really excited about 2026.
Brandon Berman
BofA Securities, Research Division
Cool. Let's start at a high level, right? There's been a significant focus on the strategic shift at the bank that you guys announced last year. From your experience, right, has the organization, the evolution positioned Ally to sort of capitalize on the strategy moving forward?
2026-02-11 02:111mo ago
2026-02-10 20:351mo ago
POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd.
, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China."
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that POMDoctor Ltd. (POM) was the Subject of a Pump-and-Dump Scheme
According to the complaint, in the weeks leading up to the December 10, 2025 initial public offering ("IPO"), POMDoctor's share price surged from the IPO price of $4.00 to an all-time high of $6.09, despite not fundamental news from the Company justifying the spike. Investigations and public reports have since revealed that POMDoctor utilized social media to orchestrate an illicit "pump-and-dump" scheme to defraud investors. Allegedly, impersonators claiming to be legitimate financial advisors touted POMDoctor in online forums, chat groups, and through social media posts with sensational but baseless claims to create a buying frenzy among retail investors. On December 10, 2025, POMDoctor's share price crashed by approximately 91% to $0.50. The Company's share price has continued to decline to approximately $0.40.
Plaintiff alleges that during the class period defendants failed to disclose to investors: (i) that POMDoctor was the subject of a fundamental stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that POMDoctor's public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity during the stock price.
What Now: You may be eligible to participate in the class action against POMDoctor Ltd. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by April 7, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against POMDoctor Ltd. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
Jumia (JMIA 15.81%) stock took a hit on Tuesday. The African e-commerce company's share price fell 15.8% in a day of trading that saw the S&P 500 decline 0.4% and the Nasdaq Composite sink 0.6%.
Jumia published its fourth-quarter results before the market opened this morning and reported sales that came in ahead of Wall Street's expectations. On the other hand, the business posted a wider-than-anticipated loss.
Image source: Getty Images.
Jumia misses Q4 earnings expectations Jumia managed to grow revenue 34.4% year over year to hit $61.4 million in the fourth quarter, beating the average analyst estimate of approximately $60.66 million. Despite the sales beat, Jumia's loss for the quarter came in higher than anticipated. The business posted a loss of $0.08 per share in the period, exceeding the average analyst estimate's call for a per-share loss of $0.05.
Today's Change
(
-15.81
%) $
-1.94
Current Price
$
10.33
What's next for Jumia? Even with today's valuation pullback, Jumia stock is still up approximately 159% over the last year. The company now has a market capitalization of approximately $1.27 billion and is valued at approximately 5.2 times this year's expected sales. k
Given Jumia's recent sales growth rate, the company could appear undervalued on a price-to-sales basis. On the other hand, the company has an uneven growth history -- and concerns remain about the business's ability to shift into delivering reliable profits.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
2026-02-11 02:111mo ago
2026-02-10 20:361mo ago
IINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc.
, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus ("HPV").
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device
According to the complaint, during the class period, defendant failed to disclose that: (i) manufacturing for Inovio's CELLECTRA device was deficient; (ii) accordingly, Inovio was unlikely to submit the INO-3107 BLA to the FDA by the second half of 2024; (iii) Inovio had insufficient information to justify the INO-3107 BLA's eligibility for FDA accelerated approval or priority review; and (iv) accordingly, INO-3107's overall regulatory and commercial prospects were overstated.
Plaintiff alleges that on August 8, 2024, Inovio issued a press release reporting its financial results and recent business highlights for the second quarter of 2024, revealing that Inovio expected to submit the INO-3107 BLA to the FDA in mid-2025—representing an approximate full-year delay from defendants' initially projected mid-2024 submission timeline—because of "a manufacturing issue" with a component of the CELLECTRA device. On this news, Inovio's stock price fell $0.27 per share, or 3.1%, to close at $8.44 per share on August 9, 2024.
Then, on December 29, 2025, Inovio issued a press release announcing that the FDA had accepted the INO-3107 BLA on a standard rather than accelerated review timeline. Because the Company did not submit adequate information to justify eligibility for accelerated approval. Defendants further advised that Inovio does not plan to seek approval under the standard review timeline and would request a meeting with the FDA to discuss how it may still pursue accelerated approval. On this news, Inovio's stock price fell $0.56 per share, or 24.45%, to close at $1.73 per share on December 29, 2025.
What Now: You may be eligible to participate in the class action against Inovio Pharmaceuticals, Inc. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by April 7, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against Inovio Pharmaceuticals, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
SOURCE Robbins LLP
2026-02-11 02:111mo ago
2026-02-10 20:381mo ago
DOOR Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Masonite International Corporation
, /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all sellers of Masonite International Corporation (NYSE: DOOR) (k/n/a Owens Corning's Doors) common stock between June 5, 2023 and February 8, 2024. Masonite is a leading global designer, manufacturer, marketer, and distributor of interior and exterior doors and door solutions for the residential and non-residential building construction markets' new construction and repair, renovation and remodeling sectors
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that Masonite International Corporation (DOOR) Misled Investors Regarding its Acquisition by Owens Corning's Doors
According to the complaint, this action arises from defendants' material omissions and misrepresentations concerning Owens Corning's offers to purchase all of Masonite's outstanding common stock at significant premiums to the Company's stock price and the Company's repurchases of millions of dollars' worth of its shares without disclosing material nonpublic information about Owens Corning's offers, which, if disclosed as required, would have indicated to investors that Masonite's stock was worth significantly more.
Plaintiff alleges that Masonite made no disclosure concerning Owens Corning's offers for approximately eight months, while the Company repurchased millions of dollars of its own shares at prices far below Owens Corning's offers. In total, Masonite repurchased nearly 270,000 of its outstanding shares from unsuspecting investors for approximately $25 million between June 2023 and December 2023, despite knowing that Owens Corning was continuously proposing offers at a significant premium to Masonite's then stock price. At the same time, defendants made numerous misleading statements touting this significant repurchase activity, repeatedly updating investors about these buybacks during the class period and telling investors the buybacks were meant to "distribut[e] capital back" to investors, all with no disclosure concerning Owens Corning's credible offer(s) to acquire Masonite shares at materially higher prices.
On February 9, 2024, Masonite issued a press release announcing the execution of the arrangement agreement. Finally, eight months after receiving the offer, defendants apprised investors that Owens Corning was willing to pay a significant premium over the market price for Masonite common stock. On this news, Masonite's common stock price skyrocketed to $130.51 at market close on February 9, 2024, a 35.1% increase over the closing price on the prior trading day.
What Now: You may be eligible to participate in the class action against Masonite International Corporation. Shareholders, who wish to serve as lead plaintiff for the class must submit their papers to the court by April 7, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.
All representation is on a contingency fee basis. Shareholders pay no fees or expenses.
About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.
To be notified if a class action against Masonite International Corporation. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.
Attorney Advertising. Past results do not guarantee a similar outcome.
SOURCE Robbins LLP
2026-02-11 02:111mo ago
2026-02-10 20:411mo ago
Curbline Properties Announces Pricing of Common Stock Offering
NEW YORK--(BUSINESS WIRE)--Curbline Properties Corp. (NYSE: CURB) (the “Company” or “Curbline”) announced today the pricing of an underwritten public offering of 8,000,000 shares of its common stock, all of which are being offered in connection with the forward sale agreements described below. The aggregate gross proceeds to the Company from the offering, before deducting estimated offering expenses, are expected to be approximately $204 million. The offering is expected to close on February 12, 2026, subject to customary closing conditions.
Morgan Stanley and BofA Securities are acting as the underwriters for the offering.
In connection with the offering, the Company entered into forward sale agreements with Morgan Stanley and BofA Securities (or affiliates thereof) (the “forward purchasers”), with respect to 8,000,000 shares of the Company’s common stock.
The underwriters have been granted a 30-day option, exercisable in whole or in part from time to time, to purchase up to an additional 1,200,000 shares of the Company’s common stock. If the option to purchase additional shares of the Company’s common stock is exercised, the Company expects to enter into one or more additional forward sale agreements with the forward purchasers in respect of the number of shares of the Company’s common stock that are subject to exercise of the option to purchase additional shares.
In connection with the forward sale agreements and any additional forward sale agreements, the forward purchasers (or their affiliates) are expected to borrow from third parties and sell to the underwriters an aggregate of 8,000,000 shares of the Company’s common stock (or an aggregate of 9,200,000 shares of the Company’s common stock if the underwriters’ option to purchase additional shares is exercised in full). However, a forward purchaser (or its affiliate) is not required to borrow and sell such shares if, after using commercially reasonable efforts, such forward purchaser (or its affiliate) is unable to borrow such shares, or if borrowing costs exceed a specified threshold or if certain specified conditions have not been satisfied. If a forward purchaser (or its affiliate) does not deliver and sell all of the shares of the Company’s common stock to be sold by it to the underwriters, the Company will issue and sell to the underwriters a number of shares of its common stock equal to the number of shares that such forward purchaser (or its affiliate) did not deliver and sell, and the number of shares underlying the relevant forward sale agreement or such additional forward sale agreement will be decreased by the number of shares that the Company issues and sells.
Pursuant to the terms of the forward sale agreements and any additional forward sale agreements, and subject to its right to elect cash or net share settlement, the Company intends to issue and sell, upon physical settlement of the forward sale agreements and any additional forward sale agreements, an aggregate of 8,000,000 shares of common stock (or an aggregate of up to 9,200,000 shares of common stock if the underwriters’ option to purchase additional shares is exercised in full) to the forward purchasers. The Company expects to physically settle the forward sale agreements and any additional forward sale agreements within approximately 18 months from the date of the prospectus supplement relating to the offering.
The Company will not receive any proceeds from the sale of shares of its common stock by the forward purchasers (or affiliates thereof). The Company intends to use the net proceeds, if any, received upon the settlement of the forward sale agreement (and from the sale of any shares of common stock sold by the Company to the underwriters in connection with this offering) for general corporate purposes, which may include, among other things, funding the acquisition of properties, working capital and capital expenditures, repaying outstanding indebtedness, or a combination of the foregoing.
All of the shares of common stock are being offered pursuant to the Company’s effective shelf registration statement filed with the Securities and Exchange Commission (the “SEC”). A final prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC. When available, a copy of the final prospectus supplement and accompanying prospectus relating to the offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd floor New York, New York 10014 or BofA Securities, Inc., NC1-022-02-25 201 North Tryon Street, Charlotte, NC 28255-0001 Attn: Prospectus Department, email: [email protected]; or by visiting the EDGAR database on the SEC’s web site at www.sec.gov.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale is not permitted. A registration statement relating to these securities has been filed with the SEC and is effective.
About Curbline Properties
Curbline Properties is an owner and manager of convenience shopping centers positioned on the curbline of well-trafficked intersections and major vehicular corridors in suburban, high household income communities. The Company is a self-managed real estate investment trust (“REIT”) that is publicly traded under the ticker symbol “CURB” on the NYSE.
Safe Harbor
Curbline Properties Corp. considers portions of the information in this press release to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, both as amended, with respect to the Company’s expectation for future periods. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that its expectations will be achieved. For this purpose, any statements contained herein that are not historical fact, including statements regarding the Company’s projected operational and financial performance, strategy, prospects and plans, may be deemed to be forward-looking statements. There are a number of important factors that could cause our results to differ materially from those indicated by such forward-looking statements, including, among other factors, changes in the economic performance and value of the Company’s properties as a result of broad economic and local conditions, such as inflation, interest rate volatility and market reaction to tariffs and other trade policies; changes in local conditions such as an increase or decrease in the supply of, or demand for, retail real estate space in our geographic markets; the impact of changes in consumer trends, distribution channels, suburban population, retailing practices and the space needs of tenants; our dependence on rental income which depends on the successful operations and financial condition of tenants, the loss of which, including as a result of store closures or bankruptcy, could result in significant occupancy loss and negatively impact rental income from our properties; our ability to enter into new leases and renew existing leases, in each case, on favorable terms; our ability to identify, acquire, construct or develop additional properties that produce the cash flows that we expect and may be limited by competitive pressures, and our ability to manage our growth effectively and capture the efficiencies of scale that we expect from expansion; potential environmental liabilities; our ability to secure debt and equity financing on commercially acceptable terms or at all; the illiquidity of real estate investments which could limit our ability to make changes to our portfolio to respond to economic or other conditions; property damage, expenses related thereto and other business and economic consequences (including the potential loss of rental revenues) resulting from climate change, natural disasters, public health crises and weather-related factors in locations where we own properties, the ability to estimate accurately the amounts thereof and the sufficiency and timing of any insurance recovery payments related to such damages; any change in strategy; the effect of future offerings of debt and equity securities on the value of our common stock; any disruption, failure or breach of the networks or systems on which the Company relies, including as a result of cyber-attacks; impairment in the value of real estate property that we own; changes in tax laws impacting REITs and real estate in general, as well as our ability to maintain our REIT status; and our ability to retain and attract key management personnel. For additional factors that could cause the results of the Company to differ materially from those indicated in the forward-looking statements, please refer to the Company’s Annual Report on Form 10-K under “Item 1A. Risk Factors” and our subsequent reports filed with the SEC. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.
More News From Curbline Properties Corp.
2026-02-11 02:111mo ago
2026-02-10 20:441mo ago
Red Rock Resorts, Inc. (RRR) Q4 2025 Earnings Call Transcript
Red Rock Resorts, Inc. (RRR) Q4 2025 Earnings Call February 10, 2026 4:30 PM EST
Company Participants
Stephen Cootey - Executive VP, CFO & Treasurer
Scott Kreeger - President
Frank Fertitta - Chairman & CEO
Lorenzo Fertitta
Conference Call Participants
David Katz - Jefferies LLC, Research Division
Benjamin Chaiken - Mizuho Securities USA LLC, Research Division
Barry Jonas - Truist Securities, Inc., Research Division
Chad Beynon - Macquarie Research
Jordan Bender - Citizens JMP Securities, LLC, Research Division
Steven Pizzella - Deutsche Bank AG, Research Division
Daniel Politzer - JPMorgan Chase & Co, Research Division
Joseph Stauff - Susquehanna Financial Group, LLLP, Research Division
Steven Wieczynski - Stifel, Nicolaus & Company, Incorporated, Research Division
Stephen Grambling - Morgan Stanley, Research Division
Brandt Montour - Barclays Bank PLC, Research Division
John DeCree - CBRE Securities, LLC, Research Division
Zachary Silverberg - Wells Fargo Securities, LLC, Research Division
Presentation
Operator
Good afternoon, and welcome to Red Rock Resorts Fourth Quarter and Full Year 2025 Conference Call. [Operator Instructions] Please note, this conference is being recorded. I would now like to turn the conference over to Stephen Cootey, Executive Vice President, Chief Financial Officer and Treasurer of Red Rock Resorts. Please go ahead.
Stephen Cootey
Executive VP, CFO & Treasurer
Thank you, operator, and good afternoon, everyone. Thank you for joining today for Red Rock Resorts Fourth Quarter and Full Year 2025 Earnings Call. Joining me on the call today are Frank and Lorenzo Fertitta, Scott Kreeger and our executive management team.
I'd like to remind everyone that our call today will include forward-looking statements under the safe harbor provisions of the United States federal securities laws. Developments and results may differ from those projected. During this call, we will also discuss non-GAAP financial measures. For definitions and complete reconciliation of these figures to GAAP, please refer to the financial tables in our earnings press release, Form 8-K and investor deck, which were
2026-02-11 02:111mo ago
2026-02-10 20:441mo ago
Mattel, Inc. (MAT) Q4 2025 Earnings Call Transcript
Mattel, Inc. (MAT) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Ynon Kreiz - Executive Chairman & CEO
Paul Ruh - Chief Financial Officer
Conference Call Participants
Arpine Kocharyan - UBS Investment Bank, Research Division
Eric Handler - ROTH Capital Partners, LLC, Research Division
James Hardiman - Citigroup Inc., Research Division
Gerrick Johnson - Seaport Research Partners
Kylie Cohu - Jefferies LLC, Research Division
Megan Christine Alexander - Morgan Stanley, Research Division
Stephen Laszczyk - Goldman Sachs Group, Inc., Research Division
Christopher Horvers - JPMorgan Chase & Co, Research Division
Presentation
Operator
Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Mattel, Inc. Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions]
I would now like to turn the call over to Greg Gilbert, Investor Relations. Greg, please go ahead.
Unknown Executive
Thank you, operator, and good afternoon, everyone. Joining me today are Ynon Kreiz, Mattel's Chairman and Chief Executive Officer; and Paul Ruh, Mattel's Chief Financial Officer.
This afternoon, we reported Mattel's Fourth Quarter and Full year 2025 financial results. We will begin today's call with Ynon and Paul providing commentary on our results, after which, we will provide some time for questions. Please note that during the question-and-answer session, we respectfully ask that you limit to 1 question and 1 follow-up so that we can get to as many analysts and questions as possible today.
Today's discussion, earnings release and slide presentation may reference certain non-GAAP financial measures and key performance indicators which are defined in the slide presentation and earnings release appendices. Please note that gross billings figures referenced on this call will be stated in constant currency unless stated otherwise. Our earnings release, slide presentation and supplemental non-GAAP information can be
2026-02-11 02:111mo ago
2026-02-10 20:451mo ago
XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-02-11 02:111mo ago
2026-02-10 20:541mo ago
Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript
Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call February 10, 2026 4:30 PM EST
Company Participants
Bianca Buck - Finance & Head of Investor Relations
Daniel Perez - Co-Founder, CEO & Director
James Pursley - President
James Budge - Chief Financial Officer
Conference Call Participants
Ryan Powderly-Gross - Barclays Bank PLC, Research Division
Jailendra Singh - Truist Securities, Inc., Research Division
Craig Hettenbach - Morgan Stanley, Research Division
Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division
Ryan MacDonald - Needham & Company, LLC, Research Division
Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division
Jessica Tassan - Piper Sandler & Co., Research Division
Rishi Jaluria - RBC Capital Markets, Research Division
Stanislav Berenshteyn - Wells Fargo Securities, LLC, Research Division
Presentation
Operator
Ladies and gentlemen, thank you for joining us, and welcome to the Hinge Health's Fourth Quarter 2025 Earnings Call. After today's prepared remarks, we will host a question-and-answer session. [Operator Instructions]
I will now hand the conference over to Bianca Buck, Head of Investor Relations. Bianca, please go ahead.
Bianca Buck
Finance & Head of Investor Relations
Good afternoon, and welcome to Hinge Health's Fourth Quarter and Full Year 2025 Earnings Call. I'm Bianca Buck, Head of Investor Relations. With me on the call are Daniel Perez, our Co-Founder and CEO; Jim Pursley, our President; and James Budge, our CFO. I want to thank everyone for joining us today.
We'll be walking you through our Q4 and 2025 annual performance, sharing updates on our product innovations and commercial momentum and providing expectations for our Q1 and full year 2026 revenue and operating profit.
As a reminder, this conference call is being recorded. All relevant materials are available on the Investor Relations section of our website. Today's discussion will include forward-looking statements which are subject to various risks, uncertainties and assumptions. These statements reflect our current views and expectations regarding future events, including
2026-02-11 02:111mo ago
2026-02-10 20:541mo ago
Exelixis, Inc. (EXEL) Q4 2025 Earnings Call Transcript
Exelixis, Inc. (EXEL) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Andrew Peters - Senior Vice President of Strategy
Michael Morrissey - CEO, President & Director
Christopher Senner - Executive VP & CFO
P. Haley - Executive Vice President of Commercial
Dana Aftab - Executive Vice President of Research & Development
Conference Call Participants
Asthika Goonewardene - Truist Securities, Inc., Research Division
Kyuwon Choi - Goldman Sachs Group, Inc., Research Division
Silvan Tuerkcan - Citizens JMP Securities, LLC, Research Division
Akash Tewari - Jefferies LLC, Research Division
Sean Laaman - Morgan Stanley, Research Division
Ruoxi Liao - Guggenheim Securities, LLC, Research Division
Sudan Loganathan - Stephens Inc., Research Division
Leonid Timashev - RBC Capital Markets, Research Division
Jason Gerberry - BofA Securities, Research Division
Stephen Willey - Stifel, Nicolaus & Company, Incorporated, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division
Eva Fortea-Verdejo - Wells Fargo Securities, LLC, Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Kalpit Patel - Wolfe Research, LLC
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. My name is [ Towanda ], and I'll be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Mr. Andrew Peters, Senior Vice President of Strategy and Investor Relations. Please proceed.
Andrew Peters
Senior Vice President of Strategy
Thank you, [ Towanda ], and thank you all for joining us for the Exelixis Fourth Quarter and Fiscal Year 2025 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; Dana Aftab, our Executive Vice President of Research and Development; and P.J. Haley, our Executive Vice President of Commercial, who will review our progress for the fourth quarter and fiscal year 2025 ended December 31, 2025.
2026-02-11 02:111mo ago
2026-02-10 20:541mo ago
OpenAI, Samsung and SK set to start building data centres in Korea in March, minister says
OpenAI logo is seen in this illustration taken May 20, 2024. REUTERS/Dado Ruvic/File Photo Purchase Licensing Rights, opens new tab
CompaniesSEOUL, Feb 11 (Reuters) - OpenAI, Samsung Electronics (005930.KS), opens new tab and SK Hynix (000660.KS), opens new tab are preparing to start construction of data centres in South Korea in March, Science Minister Bae Kyung-hoon said at a parliamentary hearing on Wednesday in Seoul.
South Korea said in October that the U.S. startup planned to set up joint ventures with the Korean firms to build two data centres in the country with an initial capacity of 20 megawatts.
The Reuters Inside Track newsletter is your essential guide to the biggest events in global sport. Sign up here.
Reporting by Heejin Kim Editing by Ed Davies
Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-02-11 02:111mo ago
2026-02-10 21:001mo ago
How Fake Invoices Duped BlackRock Unit Into a $400 Million Loan
The wipeout of a loan by BlackRock's HPS to a telecom entrepreneur points to risks for even the most sophisticated investors in the booming private-credit business.
2026-02-11 02:111mo ago
2026-02-10 21:001mo ago
Here's What Key Metrics Tell Us About Curbline (CURB) Q4 Earnings
Curbline Properties (CURB - Free Report) reported $54.15 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 55.1%. EPS of $0.29 for the same period compares to $0.11 a year ago.
The reported revenue represents a surprise of +6.56% over the Zacks Consensus Estimate of $50.82 million. With the consensus EPS estimate being $0.27, the EPS surprise was +6.62%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Curbline performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Other income: $0.17 million versus $0.45 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -38.3% change.Revenues- Rental income: $53.98 million compared to the $51.39 million average estimate based on four analysts. The reported number represents a change of +55.8% year over year.Rental income- Base and percentage rental income: $40.3 million versus the three-analyst average estimate of $38.86 million.Rental income- Recoveries from tenants: $12.48 million compared to the $12.92 million average estimate based on three analysts.Rental income- Lease termination fees, ancillary and other rental income: $1.56 million versus $0.38 million estimated by two analysts on average.View all Key Company Metrics for Curbline here>>>
Shares of Curbline have returned +6.7% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-02-11 02:111mo ago
2026-02-10 21:011mo ago
Airlines suspend Cuba flights amid jet fuel shortage after Trump tariff threats on oil shipments to island
Multiple airlines on Monday suspended flights to Cuba following warnings that the island is running low on jet fuel in the wake of President Donald Trump's tariff threats on oil shipments to the communist country.
At least three Canadian carriers, including the country’s largest airline, Air Canada, said aviation fuel is expected to be unavailable for commercial use at airports starting this week.
Other Canadian airlines, including low-cost carrier WestJet and leisure airline Air Transat, also canceled flights due to anticipated fuel shortages.
Cuban authorities issued a notice Sunday stating that aviation fuel will be unavailable at the country’s airports for one month, until March 11 at the earliest, as the Trump administration steps up economic pressure on the island nation's third-party oil suppliers.
TRUMP DECLARES NATIONAL EMERGENCY OVER CUBA, THREATENS TARIFFS ON NATIONS THAT SUPPLY OIL TO COMMUNIST REGIME
Multiple airlines on Monday suspended flights to Cuba following warnings that the island is running low on jet fuel as a result of Trump administration actions against countries that supply oil to the island nation. (Mike Campbell/NurPhoto/Getty / Getty Images)
On Monday, all three carriers issued similar notices canceling departures and announcing plans to operate repatriation flights over the coming days to retrieve customers currently in Cuba.
"Effective today it is suspending its service to Cuba due to an ongoing shortage of aviation fuel on the island," Air Canada said. "Over the following days, the airline will operate empty flights southbound to pick up approximately 3,000 customers already at their destination and return them home."
While WestJet said it will ensure its flights carry sufficient fuel to "safely depart without reliance on local fuel availability," Air Canada said its repatriation flights will arrive empty and make technical stops as necessary to refuel on the journey back.
Air Transat added that it will suspend flights to Cuba through April 30, and refund customers whose trips that have not yet begun.
TRUMP SAYS CUBA IS 'READY TO FALL' AFTER CAPTURE OF VENEZUELA'S MADURO
Air Canada has suspended service to Cuba over fuel shortages there. (Gary Hershorn/Getty Images / Getty Images)
Multiple U.S. airlines told FOX Business that American operations to the island will continue without major disruptions.
Southwest and Delta Air Lines noted that the air carriers are currently operating one flight per day to and from Havana.
"Due to the current status of aviation fuel in Cuba, Southwest Airlines is requiring aircraft that fly to Havana to carry enough fuel to also fly to their next destination," the air carrier said. "The airline currently operates one flight daily to Havana. Nothing is more important to Southwest than the Safety of our Customers and Employees."
Delta confirmed that its scheduled daily roundtrip between Miami and Havana remains unaffected by the fuel shortage, as the short route can be operated without carrying excessive fuel.
The island’s notice of a fuel shortage comes just two days after Cuban officials reportedly said air travel would not be immediately affected by the country's fuel rationing plan announced over the weekend.
According to Cuban media outlet Grito de Baire, Cuba's Minister of Transportation Eduardo Rodríguez Dávila said international airports is operating without difficulty.
AFTER MADURO, VENEZUELA FACES HARD CHOICES TO REBUILD ITS SHATTERED ECONOMY
President Donald Trump imposed sanctions on countries that supply oil to Cuba in a move aimed at increasing economic pressure on the communist-run island. (Patrick van Katwijk/Getty Images / Getty Images)
Reuters added that the Cuban Aviation Corporation published a statement Monday morning saying:
"We continue working tirelessly to ensure the safety, fluidity, and order of the airspace, supporting airline operations and ensuring that aviation in Cuba maintains the levels of reliability that characterize us."
Last month, Trump intensified economic pressure on Cuba by declaring a national emergency via an executive order in which he accused the country's communist regime of aligning with hostile foreign powers and terrorist groups while moving to punish countries that supply it with oil.
GET FOX BUSINESS ON THE GO BY CLICKING HERE
The Jan. 29 executive order, which called the Cuban government "an unusual and extraordinary threat" to the U.S. and aims to protect American national security, has effectively crippled Cuba’s energy infrastructure by prompting major foreign partners, such as Venezuela and Mexico, to halt shipments to the island.
"The United States has zero tolerance for the depredations of the communist Cuban regime," Trump said in the order, adding that the administration will act to hold the regime accountable while supporting the Cuban people’s aspirations for a free and democratic society.
FOX Business reached out to the White House and American Airlines for more information.
Fox News Digital's Jasmine Baehr and Reuters contributed to this report.
Datadog delivered a lot of good news for investors today.
Datadog (DDOG +13.96%) stock posted huge gains in Tuesday's trading. The company's share price surged 13.7% despite a 0.4% drop for the S&P 500 and a 0.6% drop for the Nasdaq Composite in the session.
Datadog published its fourth-quarter results before the market opened this morning and delivered sales and earnings that beat Wall Street's targets. The company also issued strong forward guidance.
Image source: Getty Images.
Datadog posts Q4 beats Datadog posted non-GAAP (adjusted) earnings per share of $0.59 on sales of $935 million in the fourth quarter. Adjusted earnings per share beat the average analyst estimate by $0.04, and sales came in $34.8 million higher than anticipated.
Datadog's revenue surged roughly 29% higher year over year. The business posted a gross profit of $776 million in the period -- representing a gross margin of 81.4%. Meanwhile, adjusted operating income came in at $230 million in the period -- good for a margin of 24%.
Today's Change
(
13.96
%) $
15.92
Current Price
$
129.93
What's next for Datadog? Datadog is guiding for sales between $951 million and $961 million in the current quarter -- good for year-over-year growth of 25.5% at the midpoint of the guidance range.
Meanwhile, full-year revenue is projected to be between $4.06 billion and 4.1 billion. Hitting the midpoint of that guidance range would mean increasing revenue roughly 19% on an annual basis. The company is taking a relatively conservative approach to modeling forward growth, so it wouldn't be surprising to see the business exceed that sales forecast.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Datadog. The Motley Fool has a disclosure policy.
2026-02-11 01:101mo ago
2026-02-10 19:401mo ago
Memory chip demand will be strong this year and into 2027, Samsung Elec executive says
Samsung Electronics expects strong demand for memory chips to continue this year and extend into next, a company executive said on Wednesday, citing robust demand driven by artificial intelligence.
2026-02-11 01:101mo ago
2026-02-10 19:441mo ago
Genasys Inc. (GNSS) Q1 2026 Earnings Call Transcript
Genasys Inc. (GNSS) Q1 2026 Earnings Call February 10, 2026 4:30 PM EST
Company Participants
Richard Danforth - CEO & Director
Cassandra Hernandez-Monteon - CFO, Treasurer & Secretary
Conference Call Participants
Clay Liolios
Scott Searle - ROTH Capital Partners, LLC, Research Division
Edward Woo - Ascendiant Capital Markets LLC, Research Division
Presentation
Operator
Welcome, everyone, and thank you for joining today's Genasys Inc. Fiscal First Quarter 2026 Conference Call. [Operator Instructions] A reminder, today's session is being recorded.
It is now my pleasure to turn the floor over to External Investor Relations representative, Mr. Clay Liolios. Welcome, sir.
Clay Liolios
Good afternoon, everyone. Thank you for participating in today's conference call to discuss Genasys Inc.'s Fiscal First Quarter 2026 results ended December 31, 2025. Joining us on today's call are the company's Chief Executive Officer, Richard Danforth; and Chief Financial Officer, Cassandra Monteon.
Before we begin, let me remind everyone of the company's safe harbor disclaimer. Certain portions of our comments today will concern future expectations, plans and prospects of the company that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include all statements containing verbs such as aims, anticipates, estimates, expects, believes, intends, plans, predicts, will, may, continue, projects or targets and negatives of these words and similar words or expressions. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could affect our actual results include, among others, those that are discussed under the heading Risk Factors in our most recent filed reports with the SEC, including our annual report on Form 10-K, our quarterly reports on Form 10-Q and our current reports on Form 8-K.
In addition, this call
2026-02-11 01:101mo ago
2026-02-10 19:441mo ago
Electromed, Inc. (ELMD) Q2 2026 Earnings Call Transcript
Zillow Group, Inc. (ZG) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Bradley Berning - Vice President of Investor Relations
Jeremy Wacksman - CEO & Director
Jeremy Hofmann - Chief Financial Officer
Conference Call Participants
Nicholas Jones - BNP Paribas, Research Division
Bradley Erickson - RBC Capital Markets, Research Division
Ronald Josey - Citigroup Inc., Research Division
John Colantuoni - Jefferies LLC, Research Division
Mark Stephen Mahaney - Evercore ISI Institutional Equities, Research Division
Nikhil Devnani - Bernstein Institutional Services LLC, Research Division
Trevor Young - Barclays Bank PLC, Research Division
Dae Lee - JPMorgan Chase & Co, Research Division
Lloyd Walmsley - Mizuho Americas LLC
Daniel Kurnos - The Benchmark Company, LLC, Research Division
Presentation
Operator
Hello, and welcome to Zillow Group's Fourth Quarter and Fiscal Year 2025 Financial Results Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time. Brad, you may begin.
Bradley Berning
Vice President of Investor Relations
Thank you. Good afternoon, and welcome to Zillow Group's quarterly earnings call. Joining me today to discuss our results are Zillow Group's CEO, Jeremy Wacksman; and CFO, Jeremy Hofmann.
During today's call, we will make forward-looking statements about our future performance and operating plans based on current expectations and assumptions. These statements are subject to risks and uncertainties, and we encourage you to consider the risk factors described in our SEC filings for additional information. We undertake no obligation to update these statements as a result of new information or future events, except as required by law. Please review the cautionary statement and additional information in our earnings release, which can be found on our Investor Relations website.
This call is being broadcast on the Internet and is available on our Investor Relations website. A recording of the call will be
Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call February 10, 2026 5:00 PM EST
Company Participants
Bernard Zovighian - CEO & Director
Scott Ullem - Corporate VP & CFO
Daniel Lippis - Corporate Vice President of JAPAC (Japan, Greater China & Asia Pacific)
Daveen Chopra - Corporate Vice President of Transcatheter Mitral & Tricuspid Therapies
Conference Call Participants
Robert Marcus - JPMorgan Chase & Co, Research Division
Travis Steed - BofA Securities, Research Division
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
David Roman - Goldman Sachs Group, Inc., Research Division
Joanne Wuensch - Citigroup Inc., Research Division
Matthew Taylor - Jefferies LLC, Research Division
Vijay Kumar - Evercore ISI Institutional Equities, Research Division
Presentation
Operator
Greetings, and welcome to Edwards Lifesciences' Fourth Quarter 2025 Results Conference Call.[Operator Instructions]
Please note that this conference is being recorded.
I will now turn the conference over to your host, Gerianne Sarte. Thank you. You may begin.
Unknown Executive
Thank you. Good afternoon, and thank you for joining us. This is Gerianne Sarte, I'm the incoming Senior Vice President of Investor Relations. With me on today's call is our CEO, Bernard Zovighian; and our CFO, Scott Ullem. Also joining us for the Q&A portion of the call will be Dan Lippis, our global leader of TAVR; and Daveen Chopra, who has global responsibility for TMTT, Surgical and IHFM.
Just after the close of regular trading, Edwards Lifesciences released fourth quarter and full year 2025 financial results.
During today's call, management will discuss the results included in the press release and accompanying financial schedules and then use the remaining time for Q&A. Please note that management will be making forward-looking statements that are based on estimates, assumptions and projections. These statements speak only as of the date on which they are made, and Edwards does not undertake any obligation to update them after today.
Vancouver, British Columbia, February 10, 2026 – TheNewswire - Lucky Minerals Inc. (TSXV:LKY, OTC:LKMNF, FRA:LKY) (“ Lucky ” or the “ Company ”) announces that, further to its news releases of December 20, 2023, June 13, 2025 and December 19, 2025, it further announces the following:
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Super Micro: Market Still Showing No Love For A Big AI Boost
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SMCI over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The information contained herein is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock, you should do your own research and reach your own conclusion or consult a financial advisor. Investing includes risks, including loss of principal.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
DeepMarkit Announces Voting Results of Annual General and Special Meeting
Calgary, Alberta--(Newsfile Corp. - February 10, 2026) - DeepMarkit Corp. (TSXV: MKT) (OTCID: MKTSF) (FSE: DEP0) ("DeepMarkit" or the "Company") is pleased to announce the voting results from the Company's Annual General and Special Meeting of the Shareholders (the "Meeting") held on February 10, 2026. A total of 9,364,443 common shares were voted, representing the votes attached to 15.43% of all outstanding common shares. All matters submitted to shareholders for approval as set out in the Company's Notice of Meeting and Information Circular (the "Circular"), dated December 23, 2025, as amended February 4, 2026, were approved by the requisite majority of votes cast at the Meeting. A summary of the voting results is outlined below.
Number of Directors
The number of directors of the Company was set at five (5).
Election of Directors
Steve Vanry, J. Garry Clark, Paul McKenzie, Trevor Broad, and Aydin Kilic, were elected as directors of the Company for the ensuing year.
Appointment of Auditor
SRCO Professional Corporation was re-appointed auditors of the Company for the ensuing year with the remuneration to be fixed by the directors.
Approval of Equity Incentive Plan
An ordinary resolution was passed, approving the Company's omnibus equity incentive plan.
Continuation
The special resolution to approve the Company's continuation into the Federal laws of Canada was approved.
Name Change
The special resolution authorizing the Company to amend its articles to effect the change of name from "DeepMarkit Corp." to "Prospect Prediction Markets Inc." was approved.
About DeepMarkit
DeepMarkit Corp. is a technology company enabling next-generation digital experiences across prediction markets, blockchain infrastructure, artificial intelligence, and tokenization. The Company is developing a sports prediction market platform built on the Avalanche blockchain, using a proprietary ranking algorithm to turn real-world sports events into dynamic, insight-driven markets that promote active fan participation.
On behalf of:
DEEPMARKIT CORP.
Steve Vanry
Chief Financial Officer
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/283503
Source: DeepMarkit Corp.
Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.
Contact Us
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
BYND INVESTOR REMINDER: Beyond Meat, Inc. Investors Have Until March 24, 2026 To Seek Lead Plaintiff Role
NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- If you have suffered a loss on your Beyond Meat, Inc. (“Beyond Meat” or the “Company”) (NASDAQ:BYND) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Investors have until March 24, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.
[CONTACT THE FIRM IF YOU SUFFERED A LOSS]
What Is The Lawsuit About?
The lawsuit has been filed on behalf of investors who purchased securities during the period of February 27, 2025 through November 11, 2025, inclusive (“the Class Period”). The lawsuit alleges that (i) the book value of long-lived assets exceeded their fair value, making it highly likely that the Company would be required to record a material, non-cash impairment charge; (ii) the foregoing was likely to impair Beyond Meat’s ability to timely file its periodic filings with the U.S. Securities and Exchange Commission.
On October 24, 2025, Beyond Meat reported preliminary financial results for the third quarter of 2025 (“Q3 2025”). Therein, the Company announced that it “expects to record a non-cash impairment charge for the three months ended September 27, 2025, related to certain of its long-lived assets,” which it “expected to be material.” On this news, Beyond Meat shares declined by $0.65 per share, or approximately 22.89%, to close at $2.19 on October 24, 2025.
Then, on November 3, 2025, the Company delayed its earnings announcement for 3Q 25, citing the need for more time to complete its impairment review. On this news, Beyond Meat shares declined by $0.27 per share, or approximately 16.27%, to close at $1.39 on November 3, 2025.
On November 10, 2025, Beyond Meat announced financial results for 3Q 2025, reporting a loss from operations for the quarter of $112.3 million, which included a $77.4 million non-cash impairment charge “related to certain of the Company’s long-lived assets.” On this news, Beyond Meat shares declined by $0.12 per share, or approximately 8.96%, to close at $1.22 on November 11, 2025.
Finally, on November 11, 2025, Beyond Meat disclosed on its 3Q 2025 earnings call with investors and analysts that “[t]he total impairment amount of $77.4 million was . . . allocated to PP&E, operating lease ROU assets and prepaid lease costs on our balance sheet.” On this news, Beyond Meat’s shares fell an additional $0.11 per share, or approximately 8.61%, to close at $1.12 per share on November 12, 2025.
[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]
What Should I Do?
If you purchased or otherwise acquired Beyond Meat securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at [email protected], or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.
[WHAT IS A SECURITIES CLASS ACTION?]
Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
For the quarter ended December 2025, Douglas Emmett (DEI - Free Report) reported revenue of $249.43 million, up 1.8% over the same period last year. EPS came in at $0.35, compared to -$0.01 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $255.12 million, representing a surprise of -2.23%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.35.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Douglas Emmett performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Total multifamily revenues: $49.88 million versus the two-analyst average estimate of $50.22 million. The reported number represents a year-over-year change of +3%.Revenues- Total office revenues: $199.55 million versus the two-analyst average estimate of $204.91 million. The reported number represents a year-over-year change of +1.5%.Net Earnings Per Share (Diluted): $-0.04 compared to the $-0.05 average estimate based on two analysts.View all Key Company Metrics for Douglas Emmett here>>>
Shares of Douglas Emmett have returned -5% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Lyft (LYFT) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended December 2025, Lyft (LYFT - Free Report) reported revenue of $1.59 billion, up 2.7% over the same period last year. EPS came in at -$0.20, compared to $0.30 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.76 billion, representing a surprise of -9.55%. The company delivered an EPS surprise of -162.5%, with the consensus EPS estimate being $0.32.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Lyft performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Gross Bookings: $5.07 billion versus $5.08 billion estimated by eight analysts on average.Rides: 243.5 million compared to the 256.43 million average estimate based on seven analysts.Active Riders: 29.2 million versus the six-analyst average estimate of 29.54 million.View all Key Company Metrics for Lyft here>>>
Shares of Lyft have returned -15.6% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Agree Realty (ADC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Agree Realty (ADC - Free Report) reported $190.49 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 18.5%. EPS of $1.11 for the same period compares to $0.41 a year ago.
The reported revenue represents a surprise of +1.97% over the Zacks Consensus Estimate of $186.82 million. With the consensus EPS estimate being $1.10, the EPS surprise was +1.21%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Agree Realty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Revenues- Rental income: $190.46 million compared to the $182.26 million average estimate based on two analysts. The reported number represents a change of +18.5% year over year.Revenues- Rental income- Operating cost reimbursement: $21.53 million versus the two-analyst average estimate of $19.65 million. The reported number represents a year-over-year change of +18.8%.Net Earnings Per Share (Diluted): $0.47 versus $0.46 estimated by two analysts on average.View all Key Company Metrics for Agree Realty here>>>
Shares of Agree Realty have returned +5.5% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Compared to Estimates, Rapid7 (RPD) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2025, Rapid7 (RPD - Free Report) reported revenue of $217.39 million, up 0.5% over the same period last year. EPS came in at $0.44, compared to $0.48 in the year-ago quarter.
The reported revenue represents a surprise of +1.14% over the Zacks Consensus Estimate of $214.93 million. With the consensus EPS estimate being $0.40, the EPS surprise was +8.8%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Rapid7 performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Annualized recurring revenue: $840 billion versus the six-analyst average estimate of $837.94 billion.Number of customers: 11,500 versus 11,683 estimated by two analysts on average.ARR per customer: $72,000.00 compared to the $71,902.55 average estimate based on two analysts.Revenue- Professional services: $8.24 million compared to the $6.55 million average estimate based on eight analysts. The reported number represents a change of -17% year over year.Revenue- Product subscriptions: $209.15 million compared to the $208.38 million average estimate based on eight analysts. The reported number represents a change of +1.4% year over year.Non-Gaap Gross Profit- Professional services: $1.57 million versus the eight-analyst average estimate of $1.17 million.Non-Gaap Gross Profit- Product subscriptions: $155.07 million versus $156.35 million estimated by eight analysts on average.View all Key Company Metrics for Rapid7 here>>>
Shares of Rapid7 have returned -22.7% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Compared to Estimates, Mattel (MAT) Q4 Earnings: A Look at Key Metrics
Mattel (MAT - Free Report) reported $1.77 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.3%. EPS of $0.39 for the same period compares to $0.35 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.84 billion, representing a surprise of -3.93%. The company delivered an EPS surprise of -26.18%, with the consensus EPS estimate being $0.53.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Mattel performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Worldwide Gross Billings by Top 3 Power Brands- Barbie: $415.7 million versus $442.21 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.4% change.Worldwide Gross Billings by Top 3 Power Brands- Hot Wheels: $576.4 million versus $553.84 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +19.7% change.Worldwide Gross Billings by Top 3 Power Brands- Fisher-Price: $208.9 million versus the two-analyst average estimate of $236.01 million. The reported number represents a year-over-year change of +1.4%.Worldwide Gross Billings by Top 3 Power Brands- Other: $836.6 million versus $846.85 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +6.1% change.Worldwide Gross Billings by Categories- Infant, Toddler, and Preschool: $254 million versus $301.96 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -8% change.Worldwide Gross Billings by Categories- Vehicles: $652.4 million versus the two-analyst average estimate of $627.93 million. The reported number represents a year-over-year change of +20%.Worldwide Gross Billings by Categories- Action Figures, Building Sets, Games and Other: $380.9 million compared to the $391.88 million average estimate based on two analysts. The reported number represents a change of +16.5% year over year.Worldwide Gross Billings by Categories- Dolls: $750.3 million versus $773.36 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +2.1% change.View all Key Company Metrics for Mattel here>>>
Shares of Mattel have returned +0.4% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Advanced Energy (AEIS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Advanced Energy Industries (AEIS - Free Report) reported $489.4 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 17.8%. EPS of $1.94 for the same period compares to $1.30 a year ago.
The reported revenue represents a surprise of +2.98% over the Zacks Consensus Estimate of $475.24 million. With the consensus EPS estimate being $1.77, the EPS surprise was +9.61%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Advanced Energy performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Revenue by Market- Data Center Computing: $177.9 million compared to the $178.51 million average estimate based on two analysts. The reported number represents a change of +100.6% year over year.Net Revenue by Market- Telecom and Networking: $21.7 million versus the two-analyst average estimate of $24.98 million. The reported number represents a year-over-year change of -6%.Net Revenue by Market- Semiconductor Equipment: $211.6 million versus the two-analyst average estimate of $194.55 million. The reported number represents a year-over-year change of -6.7%.Net Revenue by Market- Industrial and Medical: $78.2 million versus the two-analyst average estimate of $77.32 million. The reported number represents a year-over-year change of +1.8%.View all Key Company Metrics for Advanced Energy here>>>
Shares of Advanced Energy have returned +22.7% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
2026-02-11 01:101mo ago
2026-02-10 20:001mo ago
Teradata (TDC) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Teradata (TDC - Free Report) reported revenue of $421 million, up 2.9% over the same period last year. EPS came in at $0.74, compared to $0.53 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $395.24 million, representing a surprise of +6.52%. The company delivered an EPS surprise of +35.04%, with the consensus EPS estimate being $0.55.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Teradata performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Annual recurring revenue (ARR) - Total: $1.52 billion versus $1.5 billion estimated by two analysts on average.Annual recurring revenue (ARR) - Public Cloud: $701 million versus $696.39 million estimated by two analysts on average.Revenue- Perpetual software licenses and hardware: $1 million versus the three-analyst average estimate of $2.25 million. The reported number represents a year-over-year change of -66.7%.Revenue- Recurring: $367 million versus $345.91 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +4.6% change.Revenue- Consulting services: $53 million versus $47.41 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -3.6% change.Gross profit- Consulting services: $8 million versus $0.9 million estimated by two analysts on average.Gross profit- Recurring: $248 million versus $234.87 million estimated by two analysts on average.View all Key Company Metrics for Teradata here>>>
Shares of Teradata have returned -10.9% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.